FDA Notices of Judgment Collection, 1908-1966

Search

Search Constraints

Start Over You searched for: Collections Drugs and Devices, 1940-1963 Remove constraint Collections: Drugs and Devices, 1940-1963 Adjudicating Courts District of New Jersey Remove constraint Adjudicating Courts: District of New Jersey

Search Results

25. 2389. Misbranding of Spectro-Chrome. U. S. v. Dinshah P. Ghadiali and Dinshab Spectro-Chrome Institute. Pleas of not guilty. Tried to the jury. Verdict of guilty. Institute fined $12,000. Individual fined $8,000; sentenced to 1 year in jail on each of first 3 counts, the execution of which sentence was suspended, and placed on probation for 5 years; imposition of sentence on last 4 counts suspended. Judgment affirmed on appeal to United States Circuit Court of Appeals. Petition for writ of certiorari denied by United States Supreme Court.

27. 2422. Misbranding of Estrusol tablets and Estrusol In oil. U. S. v. Carroll Dunham Smith Pharmacal Co., Carroll Dunham Smith, Sr., Carroll Dunham Smith, Jr., and Joseph W. Kouten. Pleas of guilty. Company fined $500; fine suspended and company placed on probation for 1 year. Imposition of sentence against individuals suspended and they were placed on probation for 1 day.

45. 4082. Misbranding of dextro-amphetamine sulfate tablets, sulfadiazine tablets, and Neotrizine tablets. U. S. v. Professional Pharmacy, Inc. and Patrick J. Santangelo. Plea of guilty by corporation to all 12 counts of information; plea of guilty by individual defendant to counts 7 and 9. Corporation fined $600. Individual defendant fined $250 on count 9; imposition of sentence on count 7 against individual suspended and this defendant placed on probation for 2 years.